SARINA STEPHENS: Open Payments
NPI 1497338388 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,374 in 76 payments from 21 companies in 2025. Trend: 2023 $1,500 · 2024 $1,415 · 2025 $1,374
Food & beverage: $1,374
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $206 |
| Lilly USA, LLC | 15 | $202 |
| AstraZeneca Pharmaceuticals LP | 8 | $200 |
| GlaxoSmithKline, LLC. | 5 | $109 |
| Axsome Therapeutics, Inc. | 4 | $101 |
| ABBVIE INC. | 5 | $84 |
| Exact Sciences Corporation | 4 | $72 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $65 |
| PFIZER INC. | 3 | $54 |
| Kowa Pharmaceuticals America, Inc. | 3 | $52 |
Products named: MOUNJARO, FARXIGA, TRELEGY ELLIPTA, Auvelity, Wegovy, JARDIANCE, Ozempic, The Cologuard Plus Collection Kit.
Industry payments across AL — which companies pay providers there.
